KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · IEX Real-Time Price · USD
16.26 -0.54 (-3.21%)
Oct 25, 2021 12:46 PM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is May - April.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 12.69 | 16.13 | 8.39 | 1.5 | 2.13 | 0 | 0.03 | 0.42 | 1.54 |
| Revenue Growth | - | -21.31% | 92.13% | 458.11% | -29.49% | - | - | -93.01% | -73.02% | - |
| Gross Profit | 0 | 12.69 | 16.13 | 8.39 | 1.5 | 2.13 | 0 | 0.03 | 0.42 | 1.54 |
| Selling, General & Admin | 16.64 | 13.03 | 10.93 | 8.86 | 11.18 | 2.65 | 1.61 | 3.41 | 1.4 | 1.41 |
| Research & Development | 41.29 | 40.19 | 35.02 | 18.24 | 12.67 | 14.66 | 8.29 | 8.29 | 4.23 | 1.96 |
| Operating Expenses | 57.92 | 53.22 | 45.95 | 27.1 | 23.84 | 17.31 | 9.89 | 11.71 | 5.63 | 3.37 |
| Operating Income | -57.92 | -40.53 | -29.82 | -18.71 | -22.34 | -15.18 | -9.89 | -11.68 | -5.22 | -1.83 |
| Interest Expense / Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.08 | 0.41 | 0.26 |
| Other Expense / Income | -11.68 | -11.29 | -9.13 | -2.9 | -3.74 | -3.75 | -2.67 | 0.6 | 0.06 | -0.04 |
| Pretax Income | -46.24 | -29.24 | -20.69 | -15.81 | -18.6 | -11.44 | -7.23 | -13.36 | -5.68 | -2.05 |
| Income Tax | 0 | -0.12 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -46.24 | -29.12 | -20.82 | -15.81 | -18.6 | -11.44 | -7.23 | -13.36 | -5.68 | -2.05 |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 |
| Net Income Common | -46.24 | -29.12 | -20.82 | -15.81 | -18.6 | -11.44 | -7.23 | -13.36 | -5.68 | -2.16 |
| Shares Outstanding (Basic) | 19 | 18 | 15 | 10 | 5 | 1 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 19 | 18 | 15 | 10 | 5 | 1 | 0 | 0 | 0 | 0 |
| Shares Change | 7.58% | 17.69% | 46.11% | 122.13% | 685.86% | 124.52% | 501.93% | 44.79% | 0.45% | - |
| EPS (Basic) | -2.42 | -1.64 | -1.38 | -1.53 | -4.47 | -26.17 | -34.94 | -305.34 | -187.88 | -71.96 |
| EPS (Diluted) | -2.42 | -1.64 | -1.38 | -1.53 | -4.47 | -26.17 | -34.94 | -305.34 | -187.88 | -71.96 |
| Free Cash Flow Per Share | -1.58 | -2.54 | -2.48 | 0.89 | -5.12 | -22.27 | -24.66 | -260.83 | -161.36 | -64.02 |
| Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | 100.00% | 100.00% | 100.00% |
| Operating Margin | - | -319.41% | -184.91% | -222.84% | -1485.31% | -711.72% | - | -40265.52% | -1256.87% | -119.18% |
| Profit Margin | - | -229.44% | -129.08% | -188.29% | -1236.90% | -536.15% | - | -46065.52% | -1368.19% | -133.49% |
| Free Cash Flow Margin | - | -354.89% | -232.19% | 108.78% | -1582.18% | -617.30% | - | -39351.72% | -1174.94% | -125.23% |
| Effective Tax Rate | 0.00% | 0.42% | -0.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA | -45.59 | -28.72 | -20.31 | -15.63 | -18.56 | -11.4 | -7.19 | -12.22 | -5.25 | -1.76 |
| EBITDA Margin | - | -226.28% | -125.96% | -186.14% | -1234.24% | -534.60% | - | -42148.28% | -1264.10% | -114.37% |
| EBIT | -46.24 | -29.24 | -20.69 | -15.81 | -18.6 | -11.44 | -7.23 | -12.28 | -5.27 | -1.8 |
| EBIT Margin | - | -230.42% | -128.31% | -188.29% | -1236.90% | -536.15% | - | -42334.48% | -1270.60% | -116.84% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).